NEW YORK (GenomeWeb) – CareDx announced after the close of the market on Friday that it has closed its previously announced public offering of common stock, raising net proceeds of $53.8 million after deducting underwriting discounts and commissions and estimated offering expenses.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.